Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Fumet JD"'
Autor:
Roussot N; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Thibaudin M; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Fumet JD; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Daumoine S; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Hampe L; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Rébé C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Limagne E; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Lagrange A; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Herreros V; Department of Interventional Radiology, Centre Georges-François Leclerc, Dijon, France., Lecuelle J; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Mananet H; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ilie A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Rageot D; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Boidot R; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Goussot V; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Comte A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Jacob P; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Beltjens F; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Bergeron A; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Charon-Barra C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Arnould L; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Derangère V; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ladoire S; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Truntzer C; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ghiringhelli F; Unité Formation Recherche (UFR) des Sciences de Santé, Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Equipe Therapies and Immune Response in Cancers (TIRECS), Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Aug 07; Vol. 15, pp. 1437961. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
Autor:
Sterlé M; Pharmacy Department, Centre Georges-François Leclerc, Dijon, France.; INSERM U1231, University of Burgundy Franche-Comté, Dijon, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, Paris, France., Puszkiel A; Biologie du Médicament - Toxicologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, UMR-S1144, Paris, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, Paris, France., Burlot C; Pharmacy Department, Centre Georges-François Leclerc, Dijon, France.; INSERM U1231, University of Burgundy Franche-Comté, Dijon, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, Paris, France., Pereira E; Biologie du Médicament - Toxicologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France., Bellesoeur A; Institut Curie, Département d'Oncologie Médicale, Paris, France.; Institut Curie, Département de Radio-Pharmacologie, Saint-Cloud, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, Paris, France., De Percin S; Oncology Department, Cochin Hospital (AP-HP), CARPEM, Paris, France., Beinse G; Oncology Department, Cochin Hospital (AP-HP), CARPEM, Paris, France.; Cordeliers Research Center, Paris-Sorbonne University, INSERM, Team Personalized Medicine, Pharmacogenomics and Therapeutic Optimization, Paris, France., Fumet JD; Oncology Department, Centre Georges-François Leclerc, INSERM U1231, UFR des Sciences de Santé, Dijon, France., Favier L; Oncology Department, Centre Georges-François Leclerc, INSERM U1231, UFR des Sciences de Santé, Dijon, France., Niogret J; Oncology Department, Centre Georges-François Leclerc, INSERM U1231, UFR des Sciences de Santé, Dijon, France., Blanchet B; Biologie du Médicament - Toxicologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, Paris, France., Royer B; Pharmacology and Toxicology Laboratory, CHRU Besançon, Besançon, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, Paris, France., Bengrine-Lefevre L; Oncology Department, Centre Georges-François Leclerc, INSERM U1231, UFR des Sciences de Santé, Dijon, France., Schmitt A; Pharmacy Department, Centre Georges-François Leclerc, 1 rue Pr Marion, Dijon 21079, France.; INSERM U1231, University of Burgundy Franche-Comté, Dijon, France.; Groupe de Pharmacologie Clinique Oncologique GPCO, France.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Apr 24; Vol. 16, pp. 17588359241248328. Date of Electronic Publication: 2024 Apr 24 (Print Publication: 2024).
Autor:
Fumet JD; Department of Medical Oncology, Center GF Leclerc, Dijon, France.; Research Platform in Biological Oncology, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France., Roussot N; Department of Medical Oncology, Center GF Leclerc, Dijon, France.; Research Platform in Biological Oncology, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France., Bertaut A; Department of Epidemiology & Biostatistics, Georges François Leclerc Center, Dijon, France., Limagne E; Research Platform in Biological Oncology, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France., Thibaudin M; Research Platform in Biological Oncology, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France., Hervieu A; Department of Medical Oncology, Center GF Leclerc, Dijon, France.; Department of Medical Dermatology-Oncology, Institut Gustave Roussy, Villejuif, France., Zanetta S; Department of Medical Oncology, Center GF Leclerc, Dijon, France., Borg C; Department of Medical Oncology, University Hospital of Besancon, Besancon, France., Senellart H; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France., Pernot S; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Thuillier F; Department of Medical Oncology, University Hospital of Limoges, Limoges, France., Carnot A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Mineur L; Department of Medical Oncology, Institut Sainte Catherine, Avignon, France., Chibaudel B; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France., Touchefeu Y; Nantes Université, CHU Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), Hépato-Gastroentérologie, Inserm CIC 1413, Nantes, F-44000, France., Martin-Babau J; Department of Medical Oncology, Hopital privé des Cotes D'Armor, Plérin, France., Jary M; Department of Medical Oncology, University Hospital of Clermont Ferrand, Clermont Ferrand, France., Labourey JL; Department of Medical Oncology, Carcassonne Hospital, Carcassonne, France., Rederstorff E; Department of Epidemiology & Biostatistics, Georges François Leclerc Center, Dijon, France., Lepage C; Francois Mitterrand Hospital, Dijon, France., Ghiringhelli F; Department of Medical Oncology, Center GF Leclerc, Dijon, France.; Research Platform in Biological Oncology, Dijon, France.; GIMI Genetic & Immunology Medical Institute, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (38), pp. 3077-3085. Date of Electronic Publication: 2024 Nov 12.
Autor:
Roussot N; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Health Sciences Department, University of Burgundy, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Equipe TIRECs, Labellisée Ligue Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Vincent J; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Palmier R; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Constantin G; Department of Biostatistics, Centre Georges-François Leclerc, Dijon, France., Bengrine L; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Fumet JD; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Health Sciences Department, University of Burgundy, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Equipe TIRECs, Labellisée Ligue Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Ghiringhelli F; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Health Sciences Department, University of Burgundy, Dijon, France.; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, Dijon, France.; Equipe TIRECs, Labellisée Ligue Contre le Cancer, Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Nov 30; Vol. 13, pp. 1293670. Date of Electronic Publication: 2023 Nov 30 (Print Publication: 2023).
Autor:
Roussot N; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.; Cancer Biology Transfer Platform, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France., Fumet JD; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France. jdfumet@cgfl.fr.; Cancer Biology Transfer Platform, Dijon, France. jdfumet@cgfl.fr., Limagne E; Cancer Biology Transfer Platform, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France., Thibaudin M; Cancer Biology Transfer Platform, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; UMR INSERM 1231, Dijon, France., Hervieu A; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Hennequin A; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Zanetta S; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Dalens L; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Fourrier T; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Galland L; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Jacob P; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France., Bertaut A; Department of Epidemiology and Biostatistics, Center GF Leclerc, Dijon, France., Rederstorff E; Department of Epidemiology and Biostatistics, Center GF Leclerc, Dijon, France., Chevalier C; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Ghirardi S; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Gilbert E; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Khoukaz A; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Martin E; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Nicolet C; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Quivrin M; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Thibouw D; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Vulquin N; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Truc G; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Rouffiac M; Department of Radiotherapy, Center GF Leclerc, Dijon, France., Ghiringhelli F; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, Dijon, 21000, France.; Cancer Biology Transfer Platform, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France., Mirjolet C; UMR INSERM 1231, Dijon, France.; Radiation Oncology Department, Preclinical Radiation Therapy and Radiobiology Unit, Center GF Leclerc, Unicancer, Dijon, France.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Nov 09; Vol. 23 (1), pp. 1080. Date of Electronic Publication: 2023 Nov 09.
Autor:
Thibaudin M; Université Bourgogne Franche-Comté, Dijon, France. mthibaudin@cgfl.fr.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France. mthibaudin@cgfl.fr.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France. mthibaudin@cgfl.fr., Fumet JD; Université Bourgogne Franche-Comté, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Chibaudel B; Department of Medical Oncology, Hôpital Franco-Britannique - Fondation Cognacq-Jay, Levallois-Perret, France., Bennouna J; Department of Gastroentérology, CHU, Nantes, France., Borg C; Department of Medical Oncology, CHU, Besançon, France., Martin-Babau J; Department of Medical Oncology, Clinique CARIO, Plerin, France., Cohen R; Department of Medical Oncology, Saint Antoine, Hospital, Paris, France., Fonck M; Department of Medical Oncology, Institut Bergonie, Bordeaux, France., Taieb J; Department of Gastroenterology, Pompidou Hospital, Paris, France., Limagne E; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Blanc J; Department of Statistics, Centre Georges-François Leclerc, Dijon, France., Ballot E; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Hampe L; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Bon M; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Daumoine S; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Peroz M; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Mananet H; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Derangère V; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France., Boidot R; Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France., Michaud HA; Plateforme de Cytométrie et d'Imagerie de Masse, IRCM, University of Montpellier, ICM, Inserm Montpellier, Montpellier, France., Laheurte C; INSERM EFS UMR1098 RIGHT Interactions Hôte-Greffon-Tumeur - Ingénierie Cellulaire et Génique, Université Bourgogne Franche-Comté, Besançon, France., Adotevi O; Department of Medical Oncology, CHU, Besançon, France.; INSERM EFS UMR1098 RIGHT Interactions Hôte-Greffon-Tumeur - Ingénierie Cellulaire et Génique, Université Bourgogne Franche-Comté, Besançon, France., Bertaut A; Department of Statistics, Centre Georges-François Leclerc, Dijon, France., Truntzer C; Université Bourgogne Franche-Comté, Dijon, France.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France.; Genetic and Immunology Medical Institute, Dijon, France., Ghiringhelli F; Université Bourgogne Franche-Comté, Dijon, France. fghiringhelli@cgfl.fr.; Cancer Biology Transfer Platform, Department of Biology and Pathology of Tumors, Georges-François Leclerc Anticancer Center, UNICANCER, Dijon, France. fghiringhelli@cgfl.fr.; Centre de Recherche INSERM LNC-UMR1231, Dijon, France. fghiringhelli@cgfl.fr.; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. fghiringhelli@cgfl.fr.; Genetic and Immunology Medical Institute, Dijon, France. fghiringhelli@cgfl.fr.
Publikováno v:
Nature medicine [Nat Med] 2023 Aug; Vol. 29 (8), pp. 2087-2098. Date of Electronic Publication: 2023 Aug 10.
Autor:
Ghiringhelli F; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, France; University of Burgundy-Franche Comté, Maison de l'Université Esplanade Erasme, Dijon, France; UMR INSERM 1231, Dijon, France; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France., Bibeau F; Department of Pathology, Besançon University Hospital, Franche-Comté University, Besançon, France; Department of Pathology, Caen University Hospital, Normandy University, Caen, France., Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Aix Marseille University, Marseille, France., Fumet JD; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France; Genomic and Immunotherapy Medical Institute, Dijon University Hospital, Dijon, France; University of Burgundy-Franche Comté, Maison de l'Université Esplanade Erasme, Dijon, France; UMR INSERM 1231, Dijon, France; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France., Ilie A; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France., Monville F; Veracyte, Marseille, France., Laugé C; Veracyte, Marseille, France., Catteau A; Veracyte, Marseille, France., Boquet I; Veracyte, Marseille, France., Majdi A; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Equipe Labellisée Ligue Contre le Cancer, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Paris, France., Morgand E; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Equipe Labellisée Ligue Contre le Cancer, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Paris, France., Oulkhouir Y; Department of Thoracic Oncology, Caen University Hospital, Normandy University, Caen, France., Brandone N; Eurofins Pathologie, Bd Charles Moretti, Marseille 13014, France., Adam J; Anatomie et Cytologie Pathologiques, Hôpital Paris Saint-Joseph, INSERM, Gustave Roussy, Université Paris Saclay, Paris, France., Sbarrato T; Veracyte, Marseille, France., Kassambara A; Veracyte, Marseille, France., Fieschi J; Veracyte, Marseille, France., Garcia S; Multidisciplinary Oncology and Therapeutic Innovations Department, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Aix Marseille University, Marseille, France., Lepage AL; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, France; Department of Pathology, Besançon University Hospital, Franche-Comté University, Besançon, France., Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Aix Marseille University, Marseille, France., Galon J; Veracyte, Marseille, France; INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Equipe Labellisée Ligue Contre le Cancer, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Paris, France. Electronic address: jerome.galon@crc.jussieu.fr.
Publikováno v:
EBioMedicine [EBioMedicine] 2023 Jun; Vol. 92, pp. 104633. Date of Electronic Publication: 2023 May 25.
Autor:
Fumet JD; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges Francois Leclerc Center, Dijon, France; University of Burgundy-Franche Comté, Dijon, France. Electronic address: jd.fumet@gmail.com., Isambert N; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France., Hervieu A; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France., Zanetta S; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France., Guion JF; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France., Hennequin A; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France., Rederstorff E; Department of Epidemiology and Biostatistics, Georges, François Leclerc Center, Dijon, France., Bertaut A; Department of Epidemiology and Biostatistics, Georges, François Leclerc Center, Dijon, France., Ghiringhelli F; Department of Medical, Oncology, Center Georges Francois Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges Francois Leclerc Center, Dijon, France; University of Burgundy-Franche Comté, Dijon, France; INSERM UMR1231, Dijon, France; GIMI Genetic and Immunology, Medical Institute, Dijon, France.
Publikováno v:
ESMO open [ESMO Open] 2023 Apr; Vol. 8 (2), pp. 101185. Date of Electronic Publication: 2023 Mar 01.
Autor:
Michel E; Georges François Leclerc Cancer Center, Unicancer, Department of Surgical Oncology, Dijon, France., Mamguem Kamga A; National Quality of Life and Cancer Clinical Research Platform, Georges François Leclerc Cancer Center, Unicancer, Dijon, France., Amet A; Georges François Leclerc Cancer Center, Unicancer, Department of Surgical Oncology, Dijon, France., Padeano MM; Georges François Leclerc Cancer Center, Unicancer, Department of Surgical Oncology, Dijon, France., Fumet JD; University of Burgundy-Franche Comté, Dijon, France; Georges François Leclerc Cancer Center, Unicancer, Department of Medical Oncology, Dijon, France., Favier L; Georges François Leclerc Cancer Center, Unicancer, Department of Medical Oncology, Dijon, France., Bengrine Lefevre L; Georges François Leclerc Cancer Center, Unicancer, Department of Medical Oncology, Dijon, France., Beltjens F; Pathology Unit, Georges François Leclerc Cancer Center, Unicancer, Department of Tumour Biology, Pathology, Dijon, France., Arnould L; Pathology Unit, Georges François Leclerc Cancer Center, Unicancer, Department of Tumour Biology, Pathology, Dijon, France., Dabakuyo S; National Quality of Life and Cancer Clinical Research Platform, Georges François Leclerc Cancer Center, Unicancer, Dijon, France., Costaz H; Georges François Leclerc Cancer Center, Unicancer, Department of Surgical Oncology, Dijon, France. Electronic address: hcostaz@cgfl.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2023 Apr; Vol. 110 (4), pp. 352-359. Date of Electronic Publication: 2023 Feb 17.
Autor:
Verdez S; UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France., Albuisson J; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France.; Genomic & Immunotherapy Medical Institute, Dijon, 21000, France., Duffourd Y; UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France., Boidot R; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France.; Genomic & Immunotherapy Medical Institute, Dijon, 21000, France.; Department of Tumour Biology & Pathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France., Reda M; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France.; Department of Tumour Biology & Pathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France.; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, 1 rue Professeur Marion, Dijon, 21000, France., Thauvin-Robinet C; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France.; Genomic & Immunotherapy Medical Institute, Dijon, 21000, France.; Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs', Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France., Fumet JD; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, 1 rue Professeur Marion, Dijon, 21000, France., Ladoire S; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, 1 rue Professeur Marion, Dijon, 21000, France., Nambot S; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France.; Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs', Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France., Callier P; UMR1231 GAD, Inserm - Université Bourgogne-Franche Comté, Dijon, France.; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France., Faivre L; Unité Fonctionnelle Innovation en Diagnostic génomique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France.; Genomic & Immunotherapy Medical Institute, Dijon, 21000, France.; Centre de Référence Maladies Rares 'Anomalies du Développement et Syndromes Malformatifs', Centre de Génétique, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, 21000, France., Ghiringhelli F; Platform of Transfer in Cancer Biology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France.; Genomic & Immunotherapy Medical Institute, Dijon, 21000, France.; Department of Tumour Biology & Pathology, Georges François Leclerc Cancer Center - UNICANCER, Dijon, 21000, France.; Department of Medical Oncology, Georges François Leclerc Cancer Center - UNICANCER, 1 rue Professeur Marion, Dijon, 21000, France., Picard N; Inserm U1248, Service de Pharmacologie et Toxicologie, Université de Limoges, CHU de Limoges, Limoges, 87000, France.
Publikováno v:
Pharmacogenomics [Pharmacogenomics] 2022 Sep; Vol. 23 (14), pp. 759-770. Date of Electronic Publication: 2022 Aug 31.